Biotechnology is one of the faculty of biology which involves the study and use of living organisms. This study is done in the field of technology, medical and engineering. The detailed study of those living organism is very useful for the field of bio products. The detail study of biotechnology is only done in the field of engineering so there is a lots of scope to the biotechnology engineer in India and in all over the world. Biotechnology field is mainly deals with the field of genetics, animal cell culture, microbiology, biochemistry, molecular biology, cell biology and embryology. In India various reputed Universities are provided engineering education in biotechnology field.
As we know there are various fields in Bio technology so each field has a different scope factors but equally they have same which is the very good scope. This sector is the non-polluting sector and closely relate with the live things thus the persons who knows in the detail about this things are must needed so scope and demand are very high to the biotechnology engineer. In India the scope is very high because India has the large scale of practice in the bio technology. India has the verity and largest bio logical environment which starts to help in this study so if the person who gets the bio technological education from India; he can work itself here only.
Biotechnology
In India manpower and labor is available in on vary less costs so it is easily possible to do big experiments on the practical basis with very low costs and risks. India has largest land for growing the different types of plants which are needle requires for the agriculture-based biotechnology thus fellow can work easily in that field and can test his doubts very accurately in less time. India as well as world market business of bio technological work is growing tremendously thus opportunity if different areas of working are created very quickly so engineers are gets jobs in their concern bio technology field only. Food industry, Home products industry is totally depending upon the research which are done in the Bio technology so there is also a scope for the new ideas and researches.
Advantages of Becoming a Biotechnology Engineer
Scope in Genetic of Bio technology engineering: Genetics includes the study of plants and animals. It is based on the reformation of DNA's with appropriate organism which is also called as microbes. Today this microbes are widely use in the manufacturing various drugs and vaccinations so Medical and Drugs industry needs many people who has the detail knowledge about this field and Bio Technology engineers has the opportunity to work with those companies on high posts in research fields and the packages which are got to this people is also very handsome. There is also a job vacancy for the biotechnology engineer in plant development sector where the new techniques are to be developing for the growing of plants. Hence there has been a number of people taking up biotechnology courses for a good future career.
Advantages of Becoming a Biotechnology EngineerLA Noire: Gameplay Video Trailer Video Clips. Duration : 3.62 Mins.
Get an overview of the Rockstar crime thriller LA Noire and see exactly what the gameplay looks like in this new trailer for the game. IGN's YouTube is just a taste of our content. Get more: www.ign.com Want this week's top videos? Sign up go.ign.com
Keywords: LA Noire, ign, ignentertainment, games, gaming, video games, gameplay, la, noire, shooter, trailer, rockstar
Gary Lewis is a writer and student of the world. Currently, he helps engineers write quality Mechanical Engineer Resume to land the highest paying jobs.
Biotechnology is the branch of science that works with living organisms and the researches their functions. It has advance a great deal in the past few years and now is practically ubiquitous in our day to day lives. Biotechnology has been incorporated in the manufacture of many different products and has had resounding success in the field of medicine. The knowledge gained from the research carried on in the field of biotechnology has helped in the medicinal values of materials that before this were never imagined and made available different and new means to deal with challenges that have wrought the path of humans. This field has been growing rapidly and has made numerous advancements and breakthroughs over the last few years. It is still a highly controversial field and the reviews it has received have been mixed owing to the fact that it can be used to manipulate science.
Despite its breakthroughs this field is still in its infancy and as such is quite far away from making big profits. Few companies though have gained hugely from this science but the number of these is very limited. Since this field is mainly about research it requires large funding. These funds can be a drain on the company if the field is not really producing monetary results. Biotech companies essentially blend science and engineering to produce results. Their main aim is the welfare of the society and to that end focus on the production of medicines, food items and recycling. These companies can be divided into three main sectors namely - medicinal, agricultural and industrial. But the main developments have been in the medicinal field. They have been focusing on discovering cures for dangerous and incurable diseases.
Biotechnology
Medical Biotechnology is mainly used in the production of drugs. Many of these companies have made breakthroughs and created cures for many different diseases. This technology has been mainly used in this field to deal with the medicinal value of plants. Plants have great healing powers if used in the right quantities or combinations. These studies are carried out by researching different plants and identifying each one's medicinal properties. Then these properties are tested against different strains of bacteria to figure out is they are effective against them and to what extent. This is a time consuming process and the research just cannot be rushed. The safety of the consumers is at the very top of their priorities and as such they have to make very sure of each study.
Some Important Information on Biotechnology and Its Uses
Another important use of biotechnology is the field of Genetic Testing. This process requires a lot of precision and dedication. A process known as Gel Electrophoresis is used in the testing of DNA strands. This research can help in a myriad of way like criminal forensics, paternity testing, etc. The research pertaining to the genes responsible for breast cancer have been recently found with the use of this technology and companies are in the process of trying to isolate them reducing the risk of cancer in women.
Man's reliance on science is unending and even with all the ethical issues that are being projected on Biotechnology, it is a field that is going to be of great importance in our lives.
Some Important Information on Biotechnology and Its UsesRazy Gogonea - Britain's Got Talent 2011 Audition - itv.com/talent Tube. Duration : 4.85 Mins.
Britain's Got Talent: 28-year-old dancer Razy, originally from Romania, is trying out for Britain's Got Talent with quite a unique act, taking queues from the film The Matrix. With breakdancers being notorious on this show - from Tobias Mead and Aiden Davis to winner George Sampson - has Razy got something special that makes him different? See more at itv.com
Biotechnology is a practice as simple, and as ancient, as brewing beer or making cheese. In a practical sense, biotechnology is nothing more than humans putting to use the natural activity of microorganisms. But in the last twenty years, biotechnology
The vast application of biotechnology can be seen in food, medical and agricultural industries.
Food Industry
Biotechnology
Various types of vegetables, fruits and crops are clear signs of this field. Production of the different kinds of dairy products and beverages are miracles of biotechnology. Now, we can save our food for months and years because of biotechnology. By the help of hybridization techniques, new animals are created to obtain milk and meat. Nutritious food items are being developed, which is more beneficial for the health.
Applications of Biotechnology
Medical and Pharmaceutical Industry
New pharmaceutical drugs and medicines are coming in the markets, which are serving patients with more efficiency.
Insulin, thyroxine and all other human hormones are easily available for the use because of biotechnology. Gene therapy is a latest way to replace wrong genes in the body. Production of a factor VIII blood clotting protein for hemophiliacs is a clear example of the gene therapy. Transplantation of organs is a greatest marvel of biotechnology.
Agricultural Industry
New crops are being produced, which give more productivity in less time and area. By using different breeding techniques, new plants and fruits are being produced. The utilization of biological techniques to kill pests and other harmful herbs for crops is becoming popular.
Other Applications
Nowadays, biotechnology is used in mining industry to obtain different minerals like getting pure cooper from copper sulfate (CuSO4) by help of different bacteria.
Controversy
Techniques of cloning have produced many doubts and ambiguities. This is an alarming situation that scientists will be able to produce a human from a human cell. Lots of religious and moral problems come in this matter. So, this issue has created a question mark for this beneficial field of science.
Applications of BiotechnologyRazy Gogonea - Britain's Got Talent 2011 Audition - itv.com/talent Video Clips. Duration : 4.85 Mins.
Britain's Got Talent: 28-year-old dancer Razy, originally from Romania, is trying out for Britain's Got Talent with quite a unique act, taking queues from the film The Matrix. With breakdancers being notorious on this show - from Tobias Mead and Aiden Davis to winner George Sampson - has Razy got something special that makes him different? See more at itv.com
In clinical haematology, haematopoieses is the normal part of the analytical procedure. The breaking down and separation of the components of whole human blood can be achieved using a variety of methods, and the newer haematology analysers used today are advancing in technology to make manual counting of blood components unnecessary.
A haematology analyser uses many methods for counting human blood components, red blood cells, white blood cells, thrombocytes or platelets, and other species of cells that are common in human blood. Red blood cells have morphologies that can indicate disease or other health issues, so having an instrument for detecting these subtle changes is paramount for the diagnostician. Certain anemias can be detected with today's haematology analysers.
Biotechnology
Anemias are dysfunction in the red blood cells production. This can be evident in the size, shape, and hemoglobin content of each red blood cell (RBC). RBC's are analysed for these parameters within a hematology analyser by sorting them through a tiny aperture, which allows only one cell at a time to flow. An electronic charge field surrounds the aperture, and as the cell flows through the opening, the charge is disrupted, causing microvolt changes, which can be calculated by computer software.
How Haematology Analysers Are Used in Biotechnology Applications
Different sized cells cause a unique charge in the aperture. Shapes can also be determined in this manner, such as poikilocytosis, or the major dissimilar shaping of RBC's. Anisocytosis, or different sized cells, are detected at the same time as the unique shaped cells. This has developed into a highly advanced and technically efficient process. Diagnoses of many blood diseases can be ascertained in a matter of minutes using the hematology analyser.
White blood cells, or WBC's, are the protectors of our bodies within the blood. They combat disease and infection, and without them, we would not survive. Many diseases can be diagnosed using a haematology analyser by examining the types of WBC's present in the whole blood samples of humans. A normal white blood cell count in a male human should be from three to 10 per thousand cells, and any deviation from this is cause for alarm. Haematology analysers can count, accurately, the WBC's present in a known volume of aspirated human blood.
Morphology of the WBC's is also an important parameter in which these analysers can provide. Normal differential peripheral blood smears were usually done manually in the past, but now can be accurately ascertained using the haematology instrument. The sizes of the nucleus of cells are detected using a particle-sizing instrument that can accurately determine the size and shape of the cells being tested.
Red blood cells are also examined in this way because certain shapes of the cells can indicate diseases or defects in the blood system. Having an accurate and efficient analyser is so vital that they are found in every clinical and medical laboratory around the world. Veterinarians also use these systems for animal blood testing, as animal also procure diseases and have disorders which can wreak havoc with their health. Without the indubitable analyser in the clinical laboratory setting, many samples would be slow to results, and accuracy may be compromised.
How Haematology Analysers Are Used in Biotechnology ApplicationsHalo: Reach - Fails of the Weak Volume 31 (Funny Halo Bloopers and Screw-Ups!) Tube. Duration : 3.87 Mins.
Jack and Geoff took a lovely stroll down a wooded meadow and stumbled across a poor weeping woman. When asked about what the problem was, the woman replied "It's Friday, and I have yet to see a fail video!" Jack and Geoff laughed heartily and then provided her with this video. Enjoy.
Take a look at other relevant information about haematology analysis including chemistry analyzer content and applications as well as haematology analyser product profiles.
You want to establish a promising career in biotechnology. You have prepared an excellent resume suiting this purpose that is adorned with your work experiences and effective testimonials nevertheless; you find it difficult to set your foot. In order to present your skills, craft a striking cover letter to grab the interest of the recruiter so that they are compelled to set up an interview with you. Here is an example of a potential cover letter.
The Applicant's Name,
Current permanent address,
Current contact number,
E-mail address (not mandatory)
Biotechnology
To,
(Contact Information of your recruiter)
Date: 21st June, 2010.
Writing a Cover Letter For a Research-Based Job in the Field of Biotechnology
Dear Mr. /Mrs. Xyz,
I was pleased to discover on Findmyjob.com that the FCG Biotech Company has an opening for the post of Research Assistant in the field of Molecular Biotechnology. I believe that my credentials and my concerns go with your requirements. I have just finished my graduation this May and I want to apply for the mentioned vacancy.
As a Biotech Engineer, I have completed my studies in Genetic engineering, Micro biology, as well as, in Mathematics and Molecular Chemistry. I am presently drawn in a research assignment based on Pharmaceuticals at the Jesus and Mary Hospital, California, scrutinizing the affects of drugs on children, Genetic disorders, blood cultures for metamorphosis and Recombinant DNA technology. The previous year, I had a chance to work with PGC Pharmaceutical Company, where I contributed in Antibiotics Development and Research Studies.
I have a three years experience in the field of Biotechnology as a Teacher at the St. Agnes Convent School. I get all the errands concerning biotechnology. I am capable of working in a team as well as individually. I am able to put in efforts under pressure.
Besides my experience in the field of research and teaching, I am also involved in some extracurricular activities which include my communal services for the Society of Girls, where I actively organized a Women Scouts Day. I think that I present acute communication expertise and the aptitude to build a strong judgment according to the project needs.
You possibly are interviewing other prospective employees working in the same field. However I expect that you will not craft your final decision until I can discuss this trade with you and present my professional skills.
My Credentials are enclosed; I am awaiting an opportunity to meet you, in order to discuss this prospect. Please feel free to contact me on my number: 001-4678903 to call for an interview as per your convenience, in case you believe that I can make a potential employee. I am sincerely thankful to you, for considering my application.
Sincerely,
The Applicant's Name
Enclosures:
1. Curriculum vitae
2. Documents of qualification
3. Experience letters
4. Academic certificates.
So, I am sure that by now, you must be having an idea regarding a cover letter. I feel you will succeed in this task! So, Good luck!
Writing a Cover Letter For a Research-Based Job in the Field of BiotechnologyHalo: Reach - Fails of the Weak Volume 30 (Funny Halo Bloopers and Screw Ups!) Tube. Duration : 3.83 Mins.
Jack and Geoff polish off an awesome week with another awesome Fails of the Weak! Enjoy it and don't piss off Kat.
Tags: Achievement, Hunter, Rooster, Teeth, Bungie, Microsoft, Halo, Reach, Fails, of, the, Weak, Week, Kat, Can, Be, Very, Mean
There's a graduate degree designed to provide students with the advanced training that might help them in relatively new, or newly expanded, careers. It's known as a professional science Master's degree - and students in some instances can participate in studies part-time, even online.
Professional science graduate degrees combine studies in science with those in management, policy and law, according to the Professional Science Master's Degree Association. The Master's degrees are designed to train students for "fields of the future," according to what a Washington state university representative told a Daily Evergreen reporter in February. Some of these fields include:
Biotechnology
Atmospheric Scientists. These professionals study the atmosphere, explore climate trends and forecast the weather. Many atmospheric scientists work for the federal government, and students might want to ensure first that the college or university they select offers courses that the National Weather Service requires. While a Bachelor's degree in meteorology or a similar field is often required to embark upon a career as an atmospheric scientist, some positions require a Master's degree, and even the most basic research spots call for a PhD.
Biotechnology Allows For Advancements In Graduate Science Degrees
The US Bureau of Labor Statistics anticipates that employment for atmospheric scientists is to increase faster than average. These jobs are to be very competitive, the agency notes, making it more likely that candidates with graduate degrees will actually obtain them. Median annual wages for atmospheric scientists in May 2008 were ,290.
Agricultural and food scientists. These professionals study farm crops and animals that supply us with food and come up with ways to make them more abundant, of a better quality, and in some instances to convert them to use as fuel. Many graduates with Bachelor's degrees might expect to find work in developing products in this field, but those who prefer research might consider continuing on to a graduate degree, the Bureau of Labor Statistics reports. Median annual wages of food scientists and technologists in May 2008 were ,520.
Biological scientists. These professionals are the zoologists who study animals and the microbiologists who study tiny organisms. The work that they carry out is designed to help in solving problems related to human health and enhancing the natural environment. Graduates with Bachelor's degrees might expect to find some work in the field, though a PhD is typically required in instances where graduates hope to carry out independent research. Median annual wages of biochemists and biophysicists in May 2008 were ,840.
The Bureau of Labor Statistics anticipates faster than average employment growth for biological scientists because of the growth of biotechnological research and development. The agency also attributes biotechnology to the employment growth for agricultural and food scientists. With biotechnology, scientists have the ability to make plants hardier and resistant to pests, perhaps limiting agriculture's adverse impacts on the environment.
Biotechnology Allows For Advancements In Graduate Science DegreesMinecraft - "Shadow of Israphel" Part 5: Breakfast Distraction Video Clips. Duration : 15.20 Mins.
Simon distracts Lysander while Lewis attempts to complete Fumblemore's quest. Huge thanks to Yognaut Michael for the intro splash, Variede for the bonus cutscenes and Lalna for all his hard work, help, and superb art. Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net
Students in many instances might want to study beyond the Master's degree for some of these careers. With so many advancements in different fields these days, they might find that the offerings available to them at the graduate degree level are more varied and abundant than they were in the past such as being able to earn a Master online. Thanks to the advancements in technology, people can attend colleges online.
The primary goal of the biotechnology industry is to invent new biologically-active substances, for the treatment of disease, the pharmaceutical industry, and the management of agriculture.
The U.S. is the world leader in biotechnology, currently providing employment for more than 300,000 people in over 6,000 U.S. biotech companies, with an estimated market capitalization of approximately USD 281 billion in 2008. The biotechnology industry has more than tripled in size since 2000, with revenues increasing from USD 25 billion in 2000 to more than USD 80 billion in 2008. In 2007, Amgen, Inc., the world's largest biotechnology company, achieved total sales of USD 14.7 billion. Expectations are that the biotechnology market will increase to more than USD 130 billion by 2011.
Biotechnology
Geographically, the U.S. accounts for 65% of the biotechnology market, Europe 23%, Canada 7%, Australia 3%, and the rest of the world, 2%.
The Biotechnology Industry
Today, genomics and bioinformatics development both are being pursued within major pharmaceutical companies. There have been key collaborations with traditional IT technology companies such as IBM, Hitachi, Ltd., Samsung, SK Telecomm and Motorola. The U.S. biotechnology research and pharmaceutical industry spent a record USD 8.5 billion in 2007 on the R&D of new medicines and vaccines. As of 2006, the biotechnology industry compared favorably with the pharmaceutical industry in terms of R&D expenditures per employee. Venture capital investments in bioscience companies reached USD 11.6 billion in 2007.
Ernst & Young reported that in 2006, 82 publicly-traded Canadian biotech firms claimed S3.2 billion in revenue, accounting for 4.4% of global biotech revenues. Human health accounts for the largest segment of the Canadian biotech industry, representing more than half the interest of all biotech companies, approximately 70% of all biotech revenues and nearly 90% of all biotech R&D. Bioinforrnatics provides an important capability for the Canadian biotech industry, encompassing genomics and other "omics", tissue engineering and drug discovery technology.
Canadian bioinformatics companies include Bioinformatics Solutions, Inc., DNA LandMarks, Inc., and Kinexus Bioinformatics Corporation. Montreal, Quebec, has Canada's leading biotech cluster, followed by Toronto, Ontario; Vancouver, British Columbia; and Winnipeg, Manitoba.
Five European Union (E.U.) member states-Denmark, Finland, Germany, Sweden and the U.K.-continue to be world leaders in biotech innovation along with the U.S. and Japan. In the second half' of 2007, European biotech companies reached USD 765.3 million in venture capital investment. In January and February of 2008, venture capital funds invested a total of USD 145.6 million into new European biotech companies; however, with the economic stresses of the latter part of the year, many European biotech firms may find it harder to raise money in early 2009.
The Biotechnology Industry Organization of Germany (BlO Deutschland), located in Berlin, has more than 180 members, including companies, BioRegions, and sector service providers. The goal of the organization is to support and promote a stable economy through innovation in bioscience. Among the German biotech companies are the Biotechnology Research and Information Network (BRAIN AG), 4SC. AG, Bionas, UmbEl and Direvo, which recently (September 2008) was purchased by the German pharmaceutical and chemicals giant Bayer HealthCare. In view of' the burgeoning German biotech sector, traditional German scientific companies like Eppendorf, AG, Sartorius, AG and Qiagen also have gotten into the act.
The Biotechnology IndustryHalo: Reach - Fails of the Weak Volume 29 (Funny Halo Bloopers and Screw-Ups!) Video Clips. Duration : 4.02 Mins.
Jack and Geoff are back looking at some of the funniest fails in the world of Halo: Reach. You know you love it!
Dr. Richard Graydon, http://www.medauthor.com, trained as an Oncologist, holding both M.D. and PhD degrees, specializing in molecular genetics and cancer research. His education and experience have provided him analytical and clinical skills for keen insight into diagnosis, treatment, and care of cancer patients. See http://www.medauthor.com for further information
The biotech industry has experienced explosive growth, dwarfing that of the high tech industry. It's driven by two factors - the curiosity of its scientists and the payoff. The profits to be made are enormous, and it's these profits that are blinding its proponents and driving the debate.
It all started back in 1995 with the modification of the humble tomato. But what a Pandora's Box it opened. Today we see many varieties of genetically altered produce which, though it looks the same on the outside, is very unique in its genetic make-up. This practice of creating designer foods through gene manipulation is seen as the exiting future in agricultural farming. Geneticists tell us breathlessly that this new technology will revolutionize our lives and lead to electrifying advances in the food industry. Some of the supposed benefits of this gene-manipulation are:
o Foods more tolerant to chemicals & better resistance to pests & diseases
Biotechnology
o More nutritional content and improved food processing traits
Biotechnology - A Genetic Pandora's Box
o Resistance to unfavorable soils and weather circumstances
o Improved ripening, texture and flavor in foods
But Is It Safe?
Although the technology is impressive, the question of food safety remains skeptical and claims illusory. Genetic engineering is only in its infancy and scientists have no idea what they're messing with. By inserting genes to alter design and content, they intervene in DNA which is a self-organizing, self-replicating macromolecule, with the ability to perform error correction. Introduction of an alien gene introduces instability. The stress will cause the molecule to try and expel, or mutate the alien gene, with the result being a new structure, and the possibility of gross malfunction. This instability or undesired characteristic may not become apparent for several generations.
At this point in time, Agriculture Canada and the USDA have not identified long term health risks. All testing done to date, despite reassurances to the contrary by the biotech industry and regulatory authorities, are construed to safeguard the industry not guarantee public safety. Standard toxicology tests are conducted by the industry that benefits, no testing is done by regulatory authorities (they rely on industry data), no independent scientific tests, no long term studies, no sixth, seventh, eighth and later generation studies, and no monitoring of releases to the environment. In other words, testing is grossly one-sided. The only meaningful trials taking place are those that use the human population as involuntary guinea-pigs and the environment as an outside laboratory.
The biotech industry specializes in half-truths, downright deceptions, and extravagant claims. It comes as no surprise to learn that companies big in the manufacture and distributions of biocides (e.g. Monsanto) are also major biotech players. Nor should it come as a surprise that intense lobbying by the same companies has led to a massive increase in the permitted herbicide residues on crops. GM crops can tolerate increased herbicide applications, thus leading to a substantial increase in usage.
So we can easily see that biotechnology, rather than being used to solve agricultural problems, is more profit driven than need driven. It intensifies the farmers' dependence upon industrial inputs to legally inhibit the right of farmers to reproduce, share and store seeds. By controlling the germplasm from seed to sale and by forcing farmers to pay inflated prices for seed-chemical packages, companies are determined to extract the most profit from their investment.
Opinion polls show the world public to be overwhelmingly against genetically modified foods. In France, Britain, Denmark, USA and countries of Europe, between 68-90% of all surveyed were dogmatically against the use of GM products. The giant chemical companies are well aware of this dilemma.
(There is substantial opposition from the public, from the media, and not least, from retailers) - Leaked internal Monsanto report.
Yet we'll likely continue to dine on DNA altered cuisine without ever knowing it. Peddlers of genetically modified foods continue to slip their adulterated products onto the world market in the hope that no one will notice. Producers deliberately mix GM and non-GM products in their foods, which amounts to force-feeding an unsuspecting public. How many people in Canada know they're eating an estimated diet of 60% genetically processed foods? How many know that the US, Canada and Argentina account for more than 90% of the world's GM food crops? Absence of food labeling helps tremendously in this growing market (as it does with irradiated food).
[Labeling is the key issue ... If you put a label on genetically engineered food; you might as well put a skull and crossbones on it. - head of Asgrow, Monsanto seed subsidiary].
More genetic danger
What about ecological balance? Modified crop genes could cross-pollinate into the countryside, destroying wild habitats and creating a genetically polluted environment. Once released, genetic material can never be retrieved again. These organisms are a new life form that can mutate and breed for generations with other living things. It is a non-indigenous species that has absolutely no natural habitat outside the laboratory. Their introductions will most certainly set off elements of the environment that have a domino effect of cascading changes throughout the entire eco-system.
"If something does go badly wrong we will be faced with the problem of clearing up a kind of pollution which is self-perpetuating. I am not convinced that anyone has the first idea of how this could be done, or indeed who would have to pay." - Prince Charles, Seeds of Disaster, The Daily Telegraph, 8 June 1998
Here are a few examples of agricultural genetic failures illustrating some of the problems that have been encountered:
o The Flavr Savr tomato was a commercial disaster
o Bt-cotton suffered extensive damage from Bt-resistance pests
o Roundup Cotton shed its cotton balls when sprayed with Roundup
o A soybean with a Brazil nut gene contains a protein fatal to those with nut allergy
o Genetically modified potatoes damaged the immune system in rats
o Transgenic canola can harm bees by destroying their ability to recognize flower perfumes
These are but a few samples taken from known examples. There may be many more that we don't know about because latent genetic abnormalities have not yet surfaced. It takes only one rogue gene to cause a disaster. Biotechnology offers no benefits to the public or to the environment, only to the biotech companies which hope to make a killing. It may be a bigger killing than they anticipated. Using genetically modified crops is the same as conducting a gigantic experiment on the world's ecosystem. But with this experimentation, the ultimate price could be life itself.
"My worry is that other advances in science may result in other means of mass destruction, maybe more readily available even than nuclear weapons. Genetic engineering is quite a possible area, because of these dreadful developments that are taking place there." - Joseph Rotblat, Nobel Prize Laureate.
Sources:
1) Allen, Scott - Tinkering with DNA on Your Dinner Plate - New York Times Syndicate, 1999
2) Alison Abbot, German Physicians Warn of Genetics Risks, Nature, Vol 384 No 9, 1997
3) Andy Coghlan, The Devil We Don't Know - Virus Resistance Is What Keeps Genetic Engineers Awake At Night, New Scientist, 12 September 1996
4) Anon, Gene Food Row, News in Brief, the Sunday Times, 16 August 1998
5) Anon, Battle Lines Drawn Over Labeling of Genetically Engineered Foods, Campaigns & News, the Ecologist, July/August 1998
6) Ambassador College Agricultural Department - Genetic Engineering, Complex Path To Failure - Your Living Environment, May 1970/73,Vol.1,No.5.
7) Asda, Labeling of Genetically Modified Ingredients, Asda, 28 January 1998
8) BBC, News Item On Genetically Modified Food, The World at One, Radio 4, BBC, 10 August 1998
9) BBC, Report on Virulent and Cross-Species Viruses, Frontiers, Radio 4, BBC, 24 February 1999
10) BBC, Report on GM Crops, One Planet, BBC World Service, BBC, 16 December 1998 11) Clive Cookson, Field of Genes, Financial Times, 11 August 1998
12) Cummins, E.Joseph - More On Tinkered Genes - Alive, Canadian Journal of Health & Nutrition,Issue 3,p.135,1993.
13) FDA, Center for Food Safety & Applied Nutrition-Emerging Technologies - Biotechnology, 1995
14) FDA/CFSAN, Fed.Register - Statement of Policy: Foods Derived from New Plant Varieties - Vol.57, No.104, p.22984-22989, May 29, 1992.
15) Food Labeling; Foods Derived from New Varieties, Federal Register, April 28, 1993, Vol. 58 pages 25837-25841
Hsu, Karen - The Future Of Food Is Now - New York Times Syndicate, 1999.
16) Kendall, Patricia-Food Biotech.: Boon or Threat-Journal of Nutr. Education, 1997 - Society for Nutrit.Education.
17) McCullum,Christine - The New Biotechnology Era: Issues for Education and Policy - Journal of Nutrition Education and Policy, May/June 1997-Society for Nutritional Education.
18) P. Hatchwell, Opening Pandora's Box - The Risks of Releasing Genetically Engineered Organisms, the Ecologist, July/August 1989
21) Staunton, Dennis & Others - GM Food Threatens The Planet - Guardian Newspapers Ltd., 1999.
22) Steve Gorelick, Hiding Damaging Information From The Public, The Ecologist, Sept./Oct. 1998
23) Wales, Prince Of - Genetically Modified Food: Is It An Innovation We Can Do Without? - Online Forum, Copyright St. James Place and the Press Association Ltd. 1999
Biotechnology - A Genetic Pandora's BoxThe Invasion! : Original Short Video Clips. Duration : 2.42 Mins.
Static on the phone lines? Strange signals from Mars? It can only mean one thing! INVASION! Starring Zack Finfrock Featuring Jenn Capizzi as The Girlfriend Directed and Edited: Vincent Talenti Visual FX: Aaron Moorhead Original Score: Dan Martinez Sound Design: Julian Higgins Production Assistant: Aaron Giles *BONUS* Click below for the Original Indy Mogul Theme Ringtone! www.mediafire.com - .m4r for the iPhone www.mediafire.com - .mid for Verizon www.mediafire.com - .mp3 for anything else! To learn how to create your own Fig Rig as used in this BFX original short, check out: www.indymogul.com Indy Mogul's Original Shorts are funny short films featuring the effects and props from Indy Mogul's Backyard FX. Great filmmaking on a budget. Fun, Cheap, Filmmaking.' Website: www.indymogul.com Submit www.indymogul.com Twitter: www.twitter.com Facebook: www.facebook.com
Tags: Invasion, aliens, indymogul, funnyvideos, shortfilms, filmmaking, movies, mars, attacks, martians, war, of, the, worlds, district
Jorg Mardian is a Registered Holistic Nutritionist and Certified Fitness Trainer, with over 25 years of practical experience through thousands of clients. He is also editor of "Health in Motion," a health intelligence blog giving clear and concise information on the real truth about nutrition and causes of disease. It can be found at http://healthinmotion.wordpress.com
Overview of the Qualifying Therapeutic Discovery Project Credit
The Qualifying Therapeutic Discovery Project Credit ("the Credit") was created by Congress as part of the Patient Protection and Affordable Care Act passed on March 23, 2010. The potential incentive for small to mid-sized biotechnology companies is significant but there are limited funds available and there is a short two year window to take advantage of the incentive on a first come, first serve basis.
Biotechnology
Consequently, the time to act is now or you will miss out on this opportunity.
Lucrative New Opportunity For Small to Mid-Sized Biotechnology Companies
This article will outline the positive and negative aspects of The Credit and why you must begin the process immediately to obtain your piece of the pie.
Net Benefit Examples
Before delving into the details of the Credit, let's look at two examples of the potential benefit for eligible companies. An important aspect of the Credit is that companies cannot take the same expenses toward the Credit and the R&D Credit. (The R&D Credit may be utilized for other expenses). These examples illustrate both the size of the incentive for the Credit but also how it compares to the R&D Tax Credit.
Benefit Comparison Example: Medical Device Maker
Sampling of Activities:
Drug Delivery Devices
Treatment Delivery Systems
Therapeutic Care Equipment
Medical Monitoring Devices
Qualified Expenditures:
2009 - Million
2010 - Million
Benefit Comparison:
Estimated net benefit under the R&D Tax Credit: 5,000
Estimated net benefit under The Credit: ,625,000
Benefit Comparison Example: Biopharmaceutical Development
Sampling of Activities:
Pharmaceutical Research
Clinical Trials
Pre-Clinical Research and Testing
Qualified Expenditures:
2009: Million
2010: .5 Million
Benefit Comparison:
Estimated net benefit under the R&D Tax Credit: 2,500
Estimated net benefit under the Affordable Care Credit: 2,500
Overview of The Credit
Biotechnology firms have a lucrative opportunity to recover newly created Federal grants and tax credits. Under the Patient Protection and Affordable Care Act, eligible firms can apply for a tax credit or non-taxable cash grant in an amount equal to 50% of investments made in qualified therapeutic discovery projects. Congress mandated the creation of a new program, administered by the Secretary of the Treasury ("the Secretary"), to consider grants and credits by the end of May 2010. While the scope of activities covered by the Qualifying Therapeutic Discovery Project Credit ("the Credit") is broad, the amount of funds and years of eligibility are limited.
Broad in Scope
The Credit goes beyond existing investment tax incentives. Under the new law, expenses incurred in pursuit of any project designed to develop a "product, process, or technology" that furthers the "delivery or administration of therapeutics" are qualified. Moreover, projects designed to treat or diagnose a disease or condition may be qualified.
Consideration will be given to those projects that show reasonable potential to result in:
1) new therapies that treat areas of unmet medical need;
2) new therapies that prevent, detect, or treat chronic or acute diseases and conditions;
3) reduction of long-term health care costs in the United States; and
4) significant advancement of the goal of curing cancer within a 30-year period.
Like other investment tax credits, national job creation and retention is an important part of the law. When considering grants and credits, the Secretary will take into account the potential to create and sustain high paying U.S. jobs, as well as the potential benefit to U.S. competitiveness in the fields of life, biological, and medical sciences.
Eligible Companies
Firms that employ medical researchers, biomedical engineers, and other personnel with a background in life sciences should consider this opportunity.
Here is a list of companies that may have eligible projects for The Credit:
• Pharmaceuticals
• Medical, Drug Delivery and Health Device Manufacturers
• Biopharmaceutical Engineering Firms
• Genetic Research Firms
• Biomedical Engineering Firms
• Life Sciences Companies
• Health Sciences Companies
• Health Diagnostics Manufacturers
• Biomedical Manufacturing
• Therapeutic Treatment Companies
• Biomaterial Firms
• Tissue Engineering Companies
• Biomedical Optics Firms
• Cancer Research Companies
• Cancer Treatment Firms
• Radiology Companies
• Nanotechnology Firms
Major Benefits of The Credit
Unlike other investment tax incentives:
1. Applicants for the Credit are not required to have current taxable income.
2. Firms with no tax liability can apply for a grant in lieu of a tax credit.
3. The Credit has a statutory response time of 30 days.
a. Firms applying for the tax credit will be approved or denied by the Treasury Department within 30 days from the date of application.
b. Firms applying for a grant must be paid within 30 days from the later of the date of application or the date the qualified investment is made.
Limitations
Firms considering a grant or credit must take action now because of the following limitations:
1. Under current law, The Credit is only applicable to qualified investments made during the 2009 and 2010 tax years.
2. The amount of funds currently available is capped at billion.
3. The credit is limited to firms with 250 employees or less.
These limitations will result in intense competition for the funds currently allocated.
Program Administration
Under the new law, the Secretary must establish a program to administer the Credit not later than 60 days from the date of enactment. Though the Secretary has not released new details yet, it is clear that application and approval of funds will occur relatively quickly. Though the exact details of the program have not been released, eligible firms must begin tax planning.
Summary
In our estimation, the positive aspects of the Qualifying Therapeutic Discovery Project Credit are enormous but there is a small window of opportunity to take advantage of The Credit.
Given the administration and scrutiny of existing tax incentives, such as the R&D tax credit, those tax consultants with a background in science and engineering are particularly well suited to capture this new opportunity. Tax consultants with these qualifications are in the best position to help taxpayers properly identify qualified therapeutic investment projects. Eligible firms should contact a qualified tax advisor immediately.
Lucrative New Opportunity For Small to Mid-Sized Biotechnology CompaniesMinecraft - "Shadow of Israphel" Part 1: Crash and Burn Video Clips. Duration : 14.50 Mins.
The heroes finally return home, after a gruelling period on the Survival Island - to find that the world they left behind has changed for the worse. They must gather what resources they have and set out on a new adventure! Huge thanks to Variede for the starting cutscene and bonus stuff, subscribe to his channel here! Very reasonable rates! www.youtube.com Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net
The authors are Karim Solanji, J.D., Director and Mark Lauber, VP of Marketing both of Paradigm Partners. Paradigm Partners is a national tax consulting firm specializing in niche tax services such as the R&D Tax Credit, Qualifying Therapeutic Discovery Project Credit, the IC-DISC (U.S. Exporters' Tax Incentive), WOTC (Federal and State Hiring Tax Incentives), Section 179 and Cost Segregation. Mark's email is MLauber@ParadigmLP.com and his phone number is (281) 558-7100 X-105. Our website is http://www.ParadigmLP.com.
It is a science that deals with methods and techniques that manipulate living organisms to contribute to the betterment of human life and its environment. In a modern perspective, it includes the creation, development and modification of the genetic information of plants, animals and even human beings.
What is the scope of the science?
Biotechnology
Biotechnology has a wide range in its application. It has a relevant role in the advancement of every science, particularly in agriculture, food science, medicine and the environment.
Biotechnology FAQs
Who are qualified to practice?
Any individual who has a background in chemistry, biology, bioengineering or any science can work as a biotechnologist and carryout research and development in products such as new vaccines, cures for diseases and enhancement of wheat grains.
Why is it important?
Biotechnology helps improve man?s quality of life. With its discoveries and development, preventive measures, as well as solutions to problems have benefited human in countless ways.
What are its benefits?
There are many benefits to biotechnology. In medicine, the production of antibiotics in order to fight infections; developing of products that improve the immune system; and, discovering and treating of illnesses and disorders are huge developments.
It is also useful for the environment. It has created products that help protect and preserve endangered species. It also aids in the cleaning oil spills in oceans, as well as leaching of metal from the soil for cleaner mining. Currently, research is being conducted that concentrates on improving processes in discovering landmines and other metal contamination.
In food and agriculture, certain plants are enhanced so that they can exist in a cold environment. Genes of common salad vegetables are being altered, so they will not discolor when exposed in an open air. Stronger flowers are being developed to last longer after they have been picked.
Can it become dangerous?
It can be risky if it causes danger to the living organisms that are being used in the process of testing, as well as harm the beneficiary or the products upon using. It could also disturb the order of the ecosystem.
Biotechnology FAQsRed vs. Blue Reconstruction 19; Finale Video Clips. Duration : 9.73 Mins.
Buy the DVD: roosterteeth.com The final chapter of Red vs Blue Reconstruction. Originally aired Summer 2008.
Biotechnology provides detailed information on Biotechnology, Biotechnology Market, Biotechnology Careers, Biotechnology Schools and more. Biotechnology is affiliated with Forensic Science Colleges [http://www.e-ForensicScience.com].
Biotechnology is growing field and contributed a lot to the medical world. This technology uses the natural organisms as basic elements in producing efficient drugs for the treatment of the most dangerous diseases. Biotechnology has also natural and improved our foods.
The principle of agricultural biotechnology is not a new tradition. People are using different methods and different procedures to improve their crop and animal production. From selecting seeds from crops that increasing and leaving those that are unsuccessful, to selecting the best supply of farm animals to proliferate, mankind has been manufacturing their food and livestock to better suit their requirements. Modern agriculture uses the principle but in its place genetically modifies the crops to speed up the selection process.
Biotechnology
With the initiation and amplify in importance of Biotechnology, it is of no revelation that it is being used in the agricultural site. In fundamental nature biotechnology makes a shortcut out of the ordinary selection procedure. It does this by means of genetic engineering to generate genetically better plants that are pliable to the chosen location. Genetically engineered crops can be nutritionally richer than their "normal" matching part, can have a longer shelf-life, be disease challenging and can also be engineered to make available pharmaceutical properties.
Biotechnology Using Natural Elements
Biotech-derived plants are cautiously monitored by the United Stated Department of Agriculture (USDA) and the United States Environmental Protection Agency (USEPA). The agencies constantly monitor the effects of these lately developed plants and animals on their ecosystems and human physical condition. The agencies can either approve or disapprove the use of certain changed foods. The United States Food and Drug Agency (FDA) also monitors for human health effects of these products for potential contaminated effects. The latent of genetically engineered plants is enormous. The thought of producing plants with improved nutritional remuneration or plants that are deficiency resistant is exciting.
Biotechnology Using Natural ElementsMinecraft - "Shadow of Israphel" Part 5: Breakfast Distraction Tube. Duration : 15.20 Mins.
Simon distracts Lysander while Lewis attempts to complete Fumblemore's quest. Huge thanks to Yognaut Michael for the intro splash, Variede for the bonus cutscenes and Lalna for all his hard work, help, and superb art. Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net
Technology has revolutionized the lives of nearly all human being on the earth. The 20th century so for has been dominated by technologies based on physics and chemistry. Now, it is biology's turn. Biotechnology is the application of the exposing of biological knowledge over last twenty years, gives human kind the ability to after the structure of life itself. Biotechnology can be defined as the application of scientific and engineering principles to the processing of materials by a biological agent to provide goods and services. The scientific and engineering principles included, cover a wide range of disciplines but rely heavily on biochemistry, microbiology, genetics, biochemical and chemical engineering.
Biotechnology is doing pioneering work for human welfare. A novel targeted gone delivery system for liver cells, patented by the US, has been developed. The cloning and identification of various genes for seed storage; amino acid bio-synthesis and plant deference have been achieved. The risk and benefits of biotechnology are similar to those offered by any new technology and, if misused, the risks can lead to disastrous consequences. DNA recombinant, DNA technology, genetic cloning etc. if misused so there should be responsible governing control biotechnological research. A new advantage of biotechnology application like as plant-made pharmaceuticals has also now been developed. Much of the biological wealth on which biotechnological research depends is found in the third world. Biotechnology industry needs the gene from plants and animals, yeast and bacteria, which can still be found in forests and the wilderness of developing countries that real benefits of biotechnological research will be realized.
Biotechnology
More About Biotechnology
More About BiotechnologyMinecraft - "Shadow of Israphel" Part 5: Breakfast Distraction Video Clips. Duration : 15.20 Mins.
Simon distracts Lysander while Lewis attempts to complete Fumblemore's quest. Huge thanks to Yognaut Michael for the intro splash, Variede for the bonus cutscenes and Lalna for all his hard work, help, and superb art. Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net
Biotechnology and religion often do not mix. Consider some of the major biotechnological advances that have happened within the past decade. With each news report outlining the benefits of the new technology, it also touches on the opposition, often by religious groups.
Biotechnology and religion is a matter of ethics. Where do you draw the line between science and religion? Do religious groups have a right to try and intervene? Controversial sciences such as cloning and stem cell research will inevitably raise the question of ethics. Is it right for humans to try to spark life? Some say it is playing God. Others see it as important. It is hard to say whether or not biotechnology and religion really can mix.
Biotechnology
Do you want to understand the subject of biotechnology and religion better? The best thing to do is research. Go to your library and look up the different resources on biotechnology and also on science and how it and religion have functioned over the years. It seems that each generation has a controversial science that causes the religious to question it. The generation after that looks at the new science as normal and doesn?t think of it. Will this happen to the current field of biotechnology? Will cloning become so common that most people won't think it is strange or remarkable?
Biotechnology and Religion
It seems that biotechnology and religion don't necessarily need to compete with each other. Perhaps the issue of one versus the other has to do more with a lack of knowledge than ethics. I think that both sides will coexist better if they understood each other a little more and were more tolerant of their own differences. So when a new scientific advancement in the field of biotechnology comes out, instead of panicking and becoming outraged, perhaps opponents can practice a little understanding.
Biotechnology and ReligionMinecraft - Part 27: The Tunnel Run Video Clips. Duration : 17.00 Mins.
The grand finale to season 1 of our minecraft series!
Biotechnology provides detailed information on Biotechnology, Biotechnology Market, Biotechnology Careers, Biotechnology Schools and more. Biotechnology is affiliated with Forensic Science Colleges [http://www.e-ForensicScience.com].
What makes biotech investing especially difficult is that 90 percent of the companies have no product revenues. Therefore, standard financial analyses (EPS, growth rates, etc.) are irrelevant. Unless you want to stick with the few dozen or so profitable players, you will need to do more than "crunch the numbers." And, because the unprofitable firms have become skilled at telling their better-than-sliced bread stories, unwary investors can get duped.
This brief piece provides several warning signs to help you avoid wasting time on "never gonna happen," allowing you more time to focus on "it's gotta chance."
Biotechnology
First, look for congruency across multiple data points. No single attribute (e.g., huge market opportunity) should drive the investment. No single red flag (e.g., nepotism) should be a deal killer. Each company is different from every other and requires in-depth, highly specific investigation. You can start with a generic checklist as a crude starting point. Such a list might include, for example, the company's age, what are the accumulated deficit and the paid in capital; bigger is badder for all three. A management team that has been at the helm for 15 years and taken the ship in circles is likely to be taking investors for a ride. It is said that if something looks like a duck and quacks like a duck; it's a duck until proven otherwise. By being circumspect, you may miss an occasional gold nugget or ten bagger, but you'll buy less fool's gold and your portfolio will get sacked far less often.
Biotechnology Investing - If It Was Easy, Everyone Would Do It
Second, spend some time looking at the company's history. Usually, their web site will provide an archive of press releases (PRs). Pay special attention to projections (initiating clinical trials, finding a corporate partner, announcing clinical results). You may be surprised at how much boiler plate text is in each PR. More importantly, by tracking company projections, you will quickly discern whether the firm consistently hits its time lines or whether they just overpromise and under-deliver. Again, look for consistency of behavior.
Many investors, professional or otherwise, claim to base most of their investment decisions on confidence in management. Many a venture capitalist or fund manager has told me, "...management, management, management." Maybe you have heard that strong management can drive success from mediocre technology, but weak management is more likely to fail even with the latest gee-whiz doodad. Perhaps. But let me temper that mantra just a bit. The con in con game is short for confidence. If you are fortunate enough to meet with management, always ask a question or two to which you know the answer. One source for such a question is the company's 10-K, the formal annual report filed with the SEC. For example, in the mid-90s I learned from a 10-K that a Florida-based biotech company could conduct a clinical trial in Florida (and only in Florida) without FDA clearance. During an interview, I asked the CEO why all of his investigative sites were in Florida. Clearly flummoxed, the CEO had no answer. His response helped calibrate every answer that followed. He was very confident of his company's future success. It was ten years after our discussion that the company went bankrupt.
Here are three more red flags that should urge caution.
Most often, nepotism is a liability if only because it hints at something less than a bona fide meritocracy at work. Similarly, if you uncover a preponderance of 1) alumni from the same college, 2) brothers or sisters from the same fraternity/sorority or 3) any other hiring pattern that suggests a silly but systematic bias, be hesitant.
Be wary when there are two classes of common stock. Often, Founders, family members, or a few early investors will own the super voting class (e.g., 10 votes per share) while the rest of us may only buy regular voting shares (one vote per share). Family-run businesses often take this approach in order to maintain control. Problems can arise when family issues do not align with investors' best interests. Count the votes because they are what count when important decisions are to be made.
With several thousand biotech ventures formed over the past 30 years, coming up with a catchy, informative company name has always been a challenge. There are only so many Greek gods and goddesses from which to choose. Clearly, the nova- prefix and -gen suffix have run their course. Early stage companies will often go through a name or two before settling down. However, for other companies, a name change can be more telling. Like people, companies change their name when 1) they get married, 2) they get divorced or 3) they are hiding from their past. To paraphrase the Bard of Avon, "That which we call a rose (or stinkweed)/By any other word would smell as sweet (or fetid)." Some name changes are innocuous, e.g., reflecting a changed business model; others really are camouflage for an inglorious past.
These are only a few of the warning signals I've picked up over the past 30 years. For over 12 years I was a researcher at a large agricultural biotech company, a large pharmaceutical firm and a small biotech company. I was a venture capitalist for three years (of sixteen investments, 15 went public or got acquired) and have been an independent buyside analyst since 1995. I've heard a lot of stories.
I'm a big fan of Penn State's football coach, Joe Paterno. [Full disclosure: I earned my Ph.D. at Penn State...Go Lions!). One of the coach's key strategies has always been to maintain a strong defense. If the first rule of investing is "don't lose money," then that strategy will serve most biotechnology investors well. See, that wasn't so difficult after all.
Biotechnology Investing - If It Was Easy, Everyone Would Do ItEmerald Anniversary Tube. Duration : 20.78 Mins.
When Chris' dad buys a Chaos Emerald for a gift, Sonic and Friends, and Eggman duke it out for the emerald but Eggman unleashes Weazo and escapes with the sixth emerald while Knuckles helps Sonic defeat the robot.
Born at an early age, I have over 30 years of experience in the biotech industry. I was a laboratory scientist, a protein biuochemist, at Monsanto, Hoffmann-La Roche and California Biotechnology. At the behest of a head hunter, I joined the dark side of venture capital. Of my sixteen investments over three years, all but one went public or got acquired. But, the VC world just wasn't fun. So I started FourSquare Partners in 1997 providing independent, buyside analysis to investors. My web site at http://www.foursquarepartners.com has more.
New-Zealand's bio-tech industry is flourishing and the government is dedicated to speeding up the development of this knowledge based industry. The opportunities for investors will continue to grow as a result of the government taking a series of positive steps to promote the growth. It has established a US m venture investment fund specifically for the development of bio-tech sectors.
Biotechnology has been recognized by the NZ Government as a sector with the potential to make substantial contributions to social well being and economic growth of the country. Hence, it has been included in the Growth and Innovation Framework. The NZ government's Biotechnology Strategy was released in 2003. The primary objectives of the strategy involve promoting growth of the sector to raise economic and community welfare. It also focuses on the regulations that offer robust safeguards without obstructing innovation.
Biotechnology
In current times, most of the biotechnology research and related business is concentrated on health and well being related applications and knowledge. The NZ government has applied no restrictions on the percentage of equity a foreign investor can have in biotechnology ventures. This sector is poised for high growth due to many reasons. Biology based industries account for 60% of gross national product. Biotechnology industries in NZ have become world leaders due to investments in genetic management, process development and land management. This past foundation of scientific achievement gives the current investor a competitive edge in biotechnology projects.
Biotechnology Investment Opportunities in New Zealand
Biotechnology Industry has a legacy in NZ as the country mainly depended on commercial exports of bio tech products. NZ has a unparalleled environment which is supported by rich natural resources. This has invariably supplied the building blocks of world-class biological science. The development has been cemented by the fact that successive governments have supported the increased investment and development of biological research. Currently the primary focus is concentrated on research areas to develop medium term commercial applications in biological sciences. The government has many ranges of grants that can be availed by local and international organizations.
The royal commission of inquiry has mentioned in its report that genetic modification and its application need to be supported and NZ stands to miss huge opportunities if it fails to do so. This provides enough evidence that potential investment in biotech industries will be welcomed and supported in NZ.
Setting up a biotech industry in NZ has many advantages.
• It has a good supply of animal obtained biological materials
• Good supply of marine derived natural products
• A prominent source of raw materials for human and animal pharmaceutical products.
• Manufacture of wide range of blood based products such as antibodies and proteins.
The cost of biotechnology research and development facilities in NZ is 40% to 50% less than Europe and USA. Thus, this serves to be a great advantage for foreign investors who are looking for cost efficient research and development. The cost structure of clinical studies in New Zealand is also quite attractive. Companies can collaborate with New Zealand research groups that have strong foundations and brief history in the biological science field. Affordable access to bio-prospecting facilities, pure raw materials and NZ unique flora are some of the distinct advantages offered by NZ to foreign investors looking to invest in biotechnology projects.
Biotechnology Investment Opportunities in New ZealandMinecraft - "Shadow of Israphel" Part 1: Crash and Burn Tube. Duration : 14.50 Mins.
The heroes finally return home, after a gruelling period on the Survival Island - to find that the world they left behind has changed for the worse. They must gather what resources they have and set out on a new adventure! Huge thanks to Variede for the starting cutscene and bonus stuff, subscribe to his channel here! Very reasonable rates! www.youtube.com Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net
Investinnz.co.nz is provide details information of Investment opportunities, Events, Expos, Conferences and Magazine on investment in NZ for those who have interest to invest in New Zealand.
Think about the medical and technological advances that have occurred over the past few years. The human genome was mapped. We can clone. People are performing stem cell research and its potential to help disease. You are fascinated by the field of biotechnology. It is growing and with that comes the need for more people to fill biotechnology jobs positions.
To find biotechnology jobs you must first become qualified. If you can, get a degree in biotechnology or something that is related to biotechnology. During your schooling, see if you can find an internship or get a job that pertains to what you want to do. This will look great on your resume and can help you get a job after of college. You may also want to get an advanced degree, which can also help your chances of landing a biotechnology job.
Biotechnology
Before you apply for any biotechnological jobs you will need to write a resume. Writing a resume is a more involved process than it first seems. Your best bet is to work closely with a resume coach. They will help you learn not only what to put on your resume, but how to word it and format it for maximum results. I've heard stories where people submit a first draft resume and get no response after trying for months. Then they revamp their resume and get a job within a few days.
Biotechnology Jobs
After you get responses on your resume, it is time to start going to interviews. People think that interviews are complicated and stressful. They shouldn't be. As long as you are yourself and are honest, you should be fine. You may even end up with multiple biotechnology jobs offers.
Biotechnology jobs are available. To get a job in the biotechnologyl field you need to make sure you are qualified and get some experience in the field during college. Then, write your resume and submit them to companies looking for biotechnological experts. Once you do land a job, you will find that it is a very rewarding field
Biotechnology provides detailed information on Biotechnology, Biotechnology Market, Biotechnology Careers, Biotechnology Schools and more. Biotechnology is affiliated with Forensic Science Colleges [http://www.e-ForensicScience.com].
Nanotechnology researchers are often troubled by lack of availability of biotechnology products. However, now research itself is being claimed to have found a solution.
Nanotechnology research is an ever growing area of science, and scientists working in its realm use a variety of substances to build atomic scale structures. To solve their problem of shortage of raw materials, scientists at the Arizona State University' Biodesign Institute plan to use cells as manufacturing units to make DNA based nanostructures in a living cell.
Biotechnology
Historically, biotech products have been produced by biotechnology companies by chemically synthesizing all of the products from scratch. And much of the process entails using different toolboxes to make varied DNA nanostructures and get them to attach and organize with other molecules viz. nanoparticles and other biomolecules.
Biotechnology Products Deficit - A New Way to Vanquish It
However, now it is has been found that artificial nanostructures can be replicated using the mechanisms already present in live cells. The best part is that, you don't have to manufacture cells, and also that nature itself has endowed them with the ability to making copies of double stranded DNA. The only thing scientists have to do is to get them to make complex DNA nanostructures like a copier machine does.
When going about brainstorming for the solution, scientists thought of using the cellular system as simple DNA can be easily replicated in a cell. But the problem was that they didn't know whether the cells' replicating mechanism would tolerate single stranded DNA nanostructures that house complex secondary structures or not? In the end it did. Thus, marking the beginning of of a new way to design biotechnology products of the future.
Just the beginning though, this research appears to be quite exciting as in the future it may be used in synthetic biology applications. Perhaps as the technique is perfected, and when biotechnology companies and the biotech pharmaceutical industry implements the research full-on, there won't be any dearth of biotechnology products for scientists and the medical industry.
Biotechnology Products Deficit - A New Way to Vanquish ItMinecraft - Part 27: The Tunnel Run Tube. Duration : 17.00 Mins.
The grand finale to season 1 of our minecraft series!
Fred is a journalist with 7 years of experience. Though, as a professional He's reported on myriad topics, his favorite is the medical industry. Off late he's been working on different web portals including Themedica.com. Themedica is a comprehensive business-to-business (b2b) information portal and directory, featuring useful information for medical and health care industry professionals and businesses. It showcases resources such as trade shows, industry overviews, trade associations, global business listings, industry news, tenders, medical publications, informative articles and more that help professionals/businesses stay abreast with the latest and grow. He now blogs at Smiling Health.
Biotechnologyin its simplest sense would mean using the biological systems to develop technologies useful to man which in turn means process development and manufacture of valuable products employing biological systems. Biotechnology combines the use of biology and chemistry to develop products that improve the overall quality of human life.
Biotechnology courses are presently oriented towards educating the younger generation of students in the advances made in the field of genetic engineering and recombinant DNA technology and the emphasis is largely on the details of the techniques applied in these studies.
Biotechnology
In India, there are currently more than twenty five universities offering M Sc in Biotechnology while at least half a dozen courses in agricultural biotechnology, a couple of marine biotechnology and sundry medical biotechnology courses are also offered.
A Career In Biotechnology Makes Sense
Biotechnology graduates are qualified to work in many fields within the biotechnology industry, including pharmaceutical, manufacturing, medical, industrial products, bio-instrumentation and agriculture. Biotechnology has extraordinary potential to improve the health and well-being of people in the developing world. Biotechnology in industry employs the techniques of modern molecular biology to reduce the environmental impact of manufacturing. It no doubt is improving the safety of raw materials by helping food scientists discover the exact identity of the allergenic protein in foods such as peanuts, soybeans and milk, so they can then remove them.
Biotechnology has provided law enforcement professionals with another way of placing a suspect at the scene of a crime. Techniques of biotechnology are used in agriculture, industrial applications, forensics, manufacturing and other industries. Today, small start-up firms and multinational corporations use biotechnology in the pharmaceutical, agriculture, chemical, environmental remediation, and energy industries.
Agricultural biotechnology is used to modify plants and animals to meet consumer demand for more healthful, nutritious foods, and to produce foods in more environmentally sustainable ways.
Environmental biotechnology is the use of living organisms for a wide variety of applications in hazardous waste treatment and pollution control.
Industrial biotechnology also works to make manufacturing processes more efficient for industries such as textiles, paper and pulp, and specialty chemicals.
Another Area of study, called forensic biotechnology, uses a method called DNA fingerprinting.
The base for a scientific career in biotechnology is laid down when a student pursues plus two with physics, chemistry and biology group of subjects. The next step would be 2-year MSc in Biotechnology or 2-year M Tech for those who have completed an engineering degree. After plus two, students with physics, chemistry, biology and mathematics may also choose to pursue B Tech in Biotechnology or B Tech in Industrial Biotechnology or the recently introduced 5-year Integrated M Sc in Biotechnology or 6-year M Tech in Biotechnology courses. You can find a List ofInstitutes offering Under Graduate Courses in Biotechnology.
Combined Biotechnology Entrance Examination
is conducted by Jawaharlal Nehru University, New Delhi for admission to postgraduate programmes in Biotechnology at around twenty universities. The professional skills acquired in Biotechnology courses are applicable to the biotechnological sector especially therapeutic, cosmetic, pharmacological, diagnostic and food sectors.
The advantage of working within the biotechnology industry is that your work may have real significance in the daily lives of people everywhere. So go ahead, you have a bright future here
A Career In Biotechnology Makes SenseHalo: Reach - Achievement HORSE #2 Video Clips. Duration : 10.42 Mins.
Jack and Geoff kick off (officially) their new Halo: Reach HORSE series. This week they battle back and forth for supreme supremacy.
Anurag Chopra manages one of India's leading Education Portal for Higher Education and Entrance Exams in India. Site provides free info on Entrance Exam Dates, Admission Alerts and Notifications for MBA, Medical, Engineering, Law, Biotechnology, Accounting, UPSC, Banking and all other courses.
Man has been looking since ages to find newer cures and bring about a marked advancement in the filed of medical applications. In the last few years, biotechnology has contributed significantly towards this field.
Biotechnology
There have been significant developments in biotechnology making it one of the most lucrative investment options. Yes, biotechnology investing is considered to be the future by many investment experts.
Investing in Biotechnology - Benefits
Most venture capitalists today are looking at biotechnology companies in a different light. The opportunities for investors to generate impressive revenue growth are one of the prime reasons why this has happened.
Also the trend to spend till we get the best in health care is another reason. Man does not like to compromise when it comes to good health and biotechnology has been one of the chief gainers of this principle.
Why Biotech?
There are many small biotech companies who are waiting for that golden opportunity. Some of these companies have displayed their flair and skill in just a few years of their existence.
With the right investors these companies can work wonders. Who knows, the drug for Alzheimer's or cancer might just be underway in some of these companies.
From a business point of view, such a drug can be the single factor that will power you from rags to riches.
But biotechnology investing is not that easy. It is a task that requires a set of special skills so that you can spot the best company instantly.
Finding the right company to invest
There are many companies who will make the job of biotechnology investing easier for you, the investor.
These companies have the scientific, medical and financial experts who will analyze most biotech companies giving you comprehensive advice on which company to invest in.
With just a clinical trial, these analysts will help you determine what future prospects the company holds.
Investing in Biotechnology - BenefitsMaster's Challenge: Madworld (Machinima.com) Video Clips. Duration : 5.67 Mins.
Madworld : Chainsaws, Baseball Bats and Crotches oh my!
A common mortal from a developed country would be hard to convince that in Southeast Asia and Africa, diarrhea is responsible for as much as 8.5% and 7.7%, respectively. Yet this is the stark reality. Diarrhea is mostly caused by gastrointestinal infections. About 2.2 million people globally die of gastrointestinal-induced diarrhea. The bulk of these are children from developing countries. These are countries that lack clean drinking water- the major cause of gastrointestinal infections.
What is the role of science in ameliorating this grave situation? Many would rightly argue that provision of clean drinking water is the surest way of eradicating diarrhea. The World Health Organization (WHO) estimates that 1.1 billion people lack access to improved water sources with another 2.4 billion out of reach of basic sanitation.
Biotechnology
The world may exude optimism about providing clean drinking water to the poorest of the poor. But this remains a milieu. In the meantime, diarrhea will continue to claim the lives of millions of children, mainly from poor countries.
Using Biotechnology to Fight Diarrhea
How can science prevent these unnecessary deaths? Can it be through provision of drugs? Oh no! They are unaffordable to the poor. The poor live on less than a dollar a day.
Modern biotechnology could offer a solution. Biotechnologists have discovered a rice variety, which would produce proteins found in human milk, saliva and tears. When these proteins are converted into powder form, they can be used in granola bars and drinks to help infants in developing countries avoid death from diarrhea. This is the best way to curb runaway diarrhea in developing world such as Africa. These drinks or granola bars would be considerably cheap compared to drugs.
African farmers can also be encouraged to grow this variety of rice. First, it will boost their household income and effectively improve their living standards. It will also make the accompanying protein-rich drinks and granola bars cheaper making them accessible and affordable to all.
The biotech industry has a role to play in hastening technology diffusion. With regard to this new rice variety, for instance, they should consider domesticating its production in Africa for this is where the action is!
Rice is an important crop in most African countries. In West Africa, for instance, rice is considered a staple food. It contributes more calories and protein than any other cereal in humid West Africa. Despite the integral place that rice occupies in the diet of African consumers, its production remains pathetically poor.
Compared to other crops such as corn or soybean, improvement of rice varieties has been regrettably slow. Only one genetically transformed rice trait - tolerance to the herbicide glufosinate -is currently available in the market. It has not reached Africa yet.
"Golden rice" genetically transformed to produce pro-vitamin A is still under discussion. It is touted as a cure for Vitamin A deficiency in developing countries. It is, however, yet to be commercialized.
Using Biotechnology to Fight DiarrheaMaster's Challenge: Madworld (Machinima.com) Video Clips. Duration : 5.67 Mins.
Madworld : Chainsaws, Baseball Bats and Crotches oh my!
James Wachai is a communication specialist who uses his expertise to increase public understanding of science and technology, specifically biotechnology. Read more from James at http://www.gmoafrica.org
